LBCA Scientific Advisory Board Chair, Dr. Jason Mouabbi recently presented a research poster on invasive lobular carcinoma (ILC) at the American Society of Clinical Oncology (ASCO) annual meeting that was held May 30- June 3rd in Chicago. The ASCO event is considered one of the most significant gatherings of oncology professionals in the world. During the event, poster presentations are given as a tool to present new information in a graphic form. The posters are visual presentations of abstracts that have been submitted for consideration and publication at a conference. 

Dr. Mouabbi’s abstract titled, “The multiomic tumor microenvironment landscape of invasive lobular carcinoma of the breast” discusses the tumor microenvironment (TME) in invasive lobular carcinoma (ILC) and its critical role in tumor progression and therapeutic response. His study used a multi-faceted method for analyzing several different “omic” groups (the various disciplines in biology ending in “omics” such as genomics and proteomics) at the same time when studying the TME around ILC cells. In his presentation he described that in the past many have described ILC and their microenvironments always as “immune deserts.” However, his study supports more recent findings that indicate that some types of ILC cells might be good targets for immunotherapy. While further study is needed, his results suggest optimistically the likelihood of finding personalized therapeutic strategies for ILC.

To read the complete abstract, click here.